OPEN LABEL TRIAL OF ATOMOXETINE FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN CHILDREN WITH SPECIAL EDUCATIONAL NEEDS

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-004827-44

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

What is the efficacy of atomoxetine in reducing the symptoms of ADHD among children with moderate and severe learning disabilities and ADHD?


Critère d'inclusion

  • We will conduct a prospective, open-label pilot study of atomoxetine targeted toward symptoms of ADHD in children with learning disabilities and ADHD (Attention Deficit Hyperactivity Disorder)

Liens